Eli Lilly’s experimental drug lowers risk of heart disease by 94%: study
Pharmaceutical giant Eli Lilly’s experimental vaccine-like drug slashed a risk factor for heart disease by a whopping 94% for almost a year, according to a report. Findings from the phase 1 trial with Eli Lilly’s lepodisiran drug found that the highest dose reduced a heart disease-linked protein — which functions similarly to LDL, known as...
Related News
Top News
-
![]()
Sen. Elizabeth Warren’s defense of Biden’s mental acuity ridiculed during podcast interview“Do you regret saying that President Biden had a mental acuity, he had a sharpness to him?” Sam Fragoso, host of “Talk Easy,” asked the...
-
![]()
Kraken change course, fire Bylsma after 1 seasonThe Kraken are seeking their third head coach in as many seasons after firing Dan Bylsma. More moves are expected, including Ron Francis to...
-
![]()
-
![]()
Army suspends Col. Sheyla Baez Ramirez after Trump, Vance, Hegseth photos vanish from chain of command boardShe had served as chief of the Reserve Program, United States Army Intelligence and Security Command at Fort Belvoir, Virginia, and in other roles...
-
![]()
Senate GOP group trolls Democrats with invite for ‘one-way’ trip to El Salvador in mock travel ad“El Salvador is the destination for Democrats seeking the thrill of bringing violent, criminal, illegal aliens back to America,” the zen-like...
-
![]()
Ovechkin nets 1st playoff OT goal, Caps top HabsWashington star forward Alex Ovechkin made some personal history in the Capitals' Game 1 win over the Montreal Canadiens on Monday night, scoring...
